Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Archive
  • Info for
    • Authors
    • Reviewers
  • About Us
    • About Us
    • Conflict of Interest
    • Informed Consent
    • Human and Animal Rights
  • More
    • Alerts
    • Feedback
    • Folders
  • ascls.org
    • ascls.org

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
American Society for Clinical Laboratory Science
  • ascls.org
    • ascls.org
  • My alerts
  • Log in
  • My Cart
American Society for Clinical Laboratory Science

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Archive
  • Info for
    • Authors
    • Reviewers
  • About Us
    • About Us
    • Conflict of Interest
    • Informed Consent
    • Human and Animal Rights
  • More
    • Alerts
    • Feedback
    • Folders
  • Follow ASCLS on Twitter
  • Visit ASCLS on Facebook
  • Follow ASCLS on Instagram
  • RSS Feed
Research ArticleFocus: Hemorrhagic Abnormalities

Laboratory Management of the Bleeding Patient

Laura J Taylor
American Society for Clinical Laboratory Science April 2003, 16 (2) 111-114; DOI: https://doi.org/10.29074/ascls.16.2.111
Laura J Taylor
is a medical technologist at the University of Alabama at Birmingham, Birmingham AL
MT(ASCP)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
  • PDF
Loading

This article requires a subscription to view the full text. If you have a subscription you may use the login form below to view the article. Access to this article can also be purchased.

  1. Laura J Taylor, MT(ASCP)⇑
    1. is a medical technologist at the University of Alabama at Birmingham, Birmingham AL
  1. Address for correspondence: Laura J Taylor MT(ASCP), Department of Pathology, 619 South 19th Street, West Pavilion, P230, University of Alabama at Birmingham, Birmingham AL 35233. http://uabcoag.net

Extract

From the laboratory point of view, test results are only as reliable as the quality of the sample. It is imperative that the specimens received for coagulation testing are collected by a clean venipuncture with as little trauma to the tissues as possible. Clotted, hemolyzed, and contaminated specimens are not suitable and should not be used by the laboratory. The most common causes of erroneous results are related to the blood draw; therefore, special care must be taken to avoid any undue problems. Sodium citrate is the anticoagulant that is most commonly used for both routine and special coagulation testing. The citrated blood should be spun by routine centrifugation methods so that platelet free plasma is obtained.1

PROTHROMBIN TIME The prothrombin time (PT) monitors the factors that are in the extrinsic pathway – factors VII, X, V, and II. A PT is performed by adding synthetically prepared tissue factor, generally from brain or lung, and calcium to the test plasma and measuring the time it takes the clot to form. Prolongation of the PT is most often a result of deficiencies in factor VII but can also be caused by any of the aforementioned factors. Decreased fibrinogen, levels less than 100 mg/dL, will also prolong the PT; however, this test is not used to measure fibrinogen deficiency since most coagulation labs can perform a fibrinogen assay.1

ACTIVATED PARTIAL THROMBOPLASTIN TIME The partial thromboplastin time reagent is a preparation of synthetic phospholipids, particulate activator, and calcium. The APTT, or simply PTT,…

ABBREVIATIONS: APTT = activated partial thromboplastin time; DIC = disseminated intravascular coagulation; PT = prothrombin time; PTT = partial thromboplastin time; TCT = thrombin clotting time; vWD = von Willebrand disease; vWF = von Willebrand factor.

    INDEX TERMS
  • Disseminated intravascular coagulation
  • partial thromboplastin time
  • platelet count
  • prothrombin time
  • von Willebrand disease
  • © Copyright 2003 American Society for Clinical Laboratory Science Inc. All rights reserved.
PreviousNext
Back to top

In this issue

American Society for Clinical Laboratory Science: 16 (2)
American Society for Clinical Laboratory Science
Vol. 16, Issue 2
Spring 2003
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Front Matter (PDF)
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on American Society for Clinical Laboratory Science.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Laboratory Management of the Bleeding Patient
(Your Name) has sent you a message from American Society for Clinical Laboratory Science
(Your Name) thought you would like to see the American Society for Clinical Laboratory Science web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Laboratory Management of the Bleeding Patient
Laura J Taylor
American Society for Clinical Laboratory Science Apr 2003, 16 (2) 111-114; DOI: 10.29074/ascls.16.2.111

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Request Permissions
Share
Laboratory Management of the Bleeding Patient
Laura J Taylor
American Society for Clinical Laboratory Science Apr 2003, 16 (2) 111-114; DOI: 10.29074/ascls.16.2.111
Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
  • Info & Metrics
  • PDF

Related Articles

  • No related articles found.
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • Managing the Bleeding Patient
  • Use of Blood Products and Factor Concentrates for Coagulation Therapy
Show more Focus: Hemorrhagic Abnormalities

Similar Articles

Keywords

  • Disseminated intravascular coagulation
  • Partial Thromboplastin Time
  • platelet count
  • Prothrombin Time
  • von Willebrand disease

© 2025 The American Society for Clinical Laboratory Science

Powered by HighWire